Protara Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$40,420,000 over the previous period. Total operating expenses were $43,613,000.
Profit Margin
| 2014 | 2.94M | -3.34M | -113.36% |
|---|---|---|---|
| 2015 | 0 | -21.37M | |
| 2016 | 0 | -28.52M | |
| 2017 | 0 | -29.96M | |
| 2018 | 0 | -25.43M | |
| 2019 | 0 | -14.73M | |
| 2020 | 0 | -33.51M | |
| 2021 | 0 | -47.13M | |
| 2022 | 0 | -64.81M | |
| 2023 | 0 | -40.42M |
TARA Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.94M |
Cost of revenue | 341K | 247K | 1.16M | 196K | 16K | 0 | 148K | 0 | 57K | 0 |
Gross profit | -341K | -247K | -1.16M | -196K | -16K | 0 | -148K | 0 | -57K | 2.94M |
Operating exp. | ||||||||||
Research and development | 24.98M | 16.80M | 21.08M | 11.98M | 6.43M | 15.50M | 21.68M | 18.86M | 12.38M | 6.43M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 8.42M | 0 | -57K | 0 |
Total operating expenses | 43.61M | 37.54M | 47.48M | 34.44M | 15.25M | 26.08M | 30.21M | 28.70M | 20.81M | 10.52M |
Operating income | -43.61M | -67.06M | -47.48M | -34.44M | -15.25M | -26.08M | -30.36M | -28.70M | -20.87M | -7.58M |
Other income (expenses), net | 3.19M | 1.11M | 237K | 466K | 262K | 643K | 398K | 179K | -507K | 4.23M |
Income before tax | -40.42M | -65.95M | -47.25M | -33.97M | -14.99M | -25.43M | -29.96M | -28.52M | -21.37M | -3.34M |
Income tax expense | 0 | -1.13M | -117K | -466K | -262K | 5.35M | 657K | 372K | -363K | 5.09M |
Net income | -40.42M | -64.81M | -47.13M | -33.51M | -14.73M | -25.43M | -29.96M | -28.52M | -21.37M | -3.34M |
Earnings per share | ||||||||||
Basic EPS | -3.57 | -5.76 | -4.2 | -4.63 | -228.6 | -9.93 | -69.38 | -68.9 | -51.94 | -43.62 |
Diluted EPS | -3.57 | -5.76 | -4.2 | -4.63 | -228.6 | -9.93 | -69.38 | -68.9 | -51.94 | -43.62 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |